PRESENTATION: What happens if you miss treatment for more than a month? Gilad Rabina, MD – Tel Aviv Medical Center In nAMD patients, delayed care secondary to COVID-19 pandemic lockdowns has no significant impact on BCVA. Baseline BCVA and lower number of anti-VEGF injections are predictors for decreased visual acuity.Continue Reading
Charles Wykoff MD PhD Retinal Consultants of Houston http://www.houstonretina.com (713) 524-3434 Presentation: A Phase I/Ib Open Label, Multi-center Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With Wet Age-Related Macular Degeneration, Diabetic Macular Edema and …Continue Reading
Shailesh Gupta MD Coral Springs/Boca Raton (561) 322-3588 http://specialtyretina.com Presentation: Comparative Evaluation Of Fonts In Electronic Tablet–Assisted Improvement Of Reading Ability As Well As Quality Of Life In Patients With Poor Vision Secondary To Macular DegenerationContinue Reading
David S Boyer MD Retina-Vitrieous Associates Medical Group Adjunct Clinical Professor at USC http://www.laretina.com Los Angeles, CA Phone: (213) 483-8810 Presentation: Early treatment for dry AMD Prophylaxis Intravitreal Aflibercept Injection Against Conversion to nAMD in High-Risk Eyes (PRO-CON): 24-Month ResultsContinue Reading
Presentation: Additional Anatomic Endpoints Support Sustained Outcomes With Faricimab Every 16 Weeks in the STAIRWAY Phase 2 Trial for neovascular AMD David A Eichenbaum MDRetina Vitreous Associates of FloridaSAINT PETERSBURG (727) 323-0077CLEARWATER (727) 445-9110TAMPA (813) 879-5795 https://retinavitreous.comContinue Reading
These video interviews of outstanding researchers are produced by our Editor-In-Chief, Julie Zavala. She helps fulfill the Foundation's commitment to deliver the latest research, the progress of medical trials, breakthrough treatments for macular degeneration and practical advice on living with low vision.
In addition, the Macular Degeneration Foundation publishes a free newsletter called The MAGNIFIER, provides a telephone consultant dedicated to helping people find low-vision resources in their community, cooperates with other national and international support groups, and donates funds to qualified research facilities.